참고문헌
- Alberti, K. G. and Zimmet, P. Z. : Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 13, 539 (1998)
- Bailey, C. J. : Insulin resistance and antidiabetic drugs. Biochem. Pharmaco. 58, 1511 (1999)
- Zhang, B. B. and Moller, D. E. : New approaches in the treatment of type 2 diabetes. Curr. Opin. Chem. Biol. 4, 461 (2000)
- Ribeiro, R. C., Kushner, P. J. and Baxter, J. D. : The nuclear hormone receptor gene superfamily. Annu. Rev. Med. 46, 443 (1995)
- Spiegelman, B. M., Kim, H. E. and Brun, J. B.: PPAR-gand the control of adipogenesis. Biochimie. 79, 111 (1997)
- Vidal-Puig, A. J., Considine, R. V., Jimenez-Linan, M., Werman, A., Pories, W. J. and Caro, J. E : Peroxisome proliferator-actovated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest. 99, 2416 (1997)
- Berger, J. P., Akiyama, T. E. and Meinke, P. T. : PPARs: therapeutic targets for metabolic disease. Trends Parmacol. Sci. 26, 244 (2005) https://doi.org/10.1016/j.tips.2005.03.003
- Staels, B. and Fruchart, J. C.: Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes. 54, 2460 (2005) https://doi.org/10.2337/diabetes.54.8.2460
-
Chawia, A., Schwarz, E. J., Dimaculangan, D. D. and Lazar, M. A. : Peroxisome proliferator-activated receptor (PPAR)
${\gamma}$ : adipose-predominant exression and induction early in adipocyte differentiation. Endocrinology 135, 798 (1994) -
Tontonoz, P., Hu, E. and Spiegelman, B. M. : Stimulation of adipogenesis in fibroblasts by PPAR
${\gamma}2$ , a lipid-activated transcription factor Cell. 79, 1147 (1994) - Sood, V, Colleran, K. and Burge, M. R. : Thiazolidinedions: a comparative review of approved uses. Diaetes. Technol. Ther. 2, 429 (2000)
- Lebovitz, H. E. : Dfferentiating members of th thiazoli-dinedione class: a focus on safety. Diabetes. Meta. Res. Rev. 18, 23 (2002)
- Oberfield, J. L., Collins, J. L., Holmes, C. P., Goreham, D. M., Cooper, J. P. and Cobb, J. E. : A peroxisome proliferator-activated receptor ligand inhibits adipocyte differentiation. Proc. Natl. Acad. Sci. 96, 6102 (1999)
-
Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N. and Zeyer, D. : A unique PPAR-
${\gamma}$ ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell. 8, 737 (2001) - Misra, E, Chakrabarti, R., Vikramadithyan, R. K., Bolusu, G., Juluri, S. and Hiriyan, J. : PAT5A: a partial agonist of peroxisome proliferator-activated receptor g is a potent antidiabetic thiazolidinedione yet weakly adipogenic J. Pharmacol. Exp. Ther. 306, 763 (2003) https://doi.org/10.1124/jpet.103.049791
- Berger, J. P., Petro, A. E., Macnaul, K. L., Kelly, L. J., Zhang, B. B. and Richards, K.: Distinct properties and advantages of a novel peroxisome proliferator-activated protein [g] selective modulator. Mol. Endocrinol. 17, 662 (2003) https://doi.org/10.1210/me.2002-0217
-
Huang, C., Zhang, Y., Gong, Z., Sheng, X., Li, Z., Zhang, W. and Zin, Y. : Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR-
${\gamma}$ pathway. Biochem. Biophys. Res. Commun. 348, 571 (2006) https://doi.org/10.1016/j.bbrc.2006.07.095 -
Chakrabrti, R., Misra, P., Vikramadithyan, R. K., Premkumar, M., Hiriyan, J., Datla, S. R., Damarla, R. K., suresh, J. and Rajagopalan, R. : Antidiabetic and hypolipidemic potential of DRF 2519-a dual activator of PPAR-
${\alpha}$ and PPAR-${\gamma}$ . Eur. J. Pharmacol. 491, 195 (2004) https://doi.org/10.1016/j.ejphar.2004.03.034 - Trinder, P. : Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22, 158 (1969)
- Chomczynski, P. and Sacchi, N. : Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal. Biochem. 162(1), 156 (1987)